Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal

Epidemics

Volumn 18, Issue , 2017, Pages 4-15

  Walker, Martin ^a,b   Stolk, Wilma A ^c   Dixon, Matthew A ^a,c,d   Bottomley, Christian ^c,d   Diawara, Lamine ^e   Traoré, Mamadou O ^f   de Vlas, Sake J ^c   Basáñez, María Gloria ^a,c,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f Programme National de Lutte contre l'Onchocercose (PNLO)   (Mali)

Author keywords

Elimination; Mathematical modelling; Onchocerciasis; River blindness; Surveillance

Indexed keywords

IVERMECTIN;

ARTICLE; COMMUNITY; MALI; OCULAR ONCHOCERCIASIS; PREVALENCE; PRIORITY JOURNAL; SENEGAL; VECTOR CONTROL; HUMAN; TRANSMISSION;

HUMANS; IVERMECTIN; MALI; ONCHOCERCIASIS, OCULAR; PREVALENCE; SENEGAL;

EID: 85014570789     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2017.02.005     Document Type: Article

References (65)

1. African Programme for Onchocerciasis Control, Operational Framework of Onchocerciasis Elimination with Ivermectin Treatment. WHO/APOC/MG/10.1., 2010, World Health Organization, Geneva, Switzerland Available at: http://www.who.int/apoc/oncho_ elimination_report_english.pdf. Accessed 22 August 2016.
2. African Programme for Onchocerciasis Control (APOC), Eighteenth Session of the Joint Action Forum. 2012 Available: http://www.who.int/apoc/about/structure/jaf/Final_Communique_JAF_18_English_final_with_annexes.pdf. Accessed 22 August 2016.
3. Anderson, R.M., May, R.M., Infectious Diseases of Humans: Dynamics and Control. 1991, Oxford University Press, Oxford.
4. Awadzi, K., Opoku, N.O., Attah, S.K., Lazdins-Helds, J., Kuesel, A.C., A randomized, single-ascending dose, ivermectin-controlled double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl. Trop. Dis., 8, 2014, e2953, 10.1371/journal.pntd.0002953).
5. Basáñez, M.G., Boussinesq, M., Population biology of human onchocerciasis. Philos. Trans. R. Soc. Lond. B: Biol. 354 (1999), 809–826.
6. Basáñez, M.G., Collins, R.C., Porter, C.H., Little, M.P., Brandling-Bennett, D., Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am. J. Trop. Med. Hyg. 67 (2002), 669–679.
7. Basáñez, M.G., Pion, S.D.S., Boakes, E., Filipe, J.A.N., Churcher, T.S., Boussinesq, M., Effect of single dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect. Dis. 8 (2008), 310–322, 10.1016/S1473-3099(08)70099-9.
8. Basáñez, M.G., Churcher, T.S., Grillet, M.E., Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv. Parasitol. 68 (2009), 263–313, 10.1016/S0065-308X(08)00611-8.
9. Basáñez, M.G., French, M.D., Walker, M., Churcher, T.S., Paradigm lost: how parasite control may alter pattern and process in human helminthiases. Trends Parasitol. 28 (2012), 161–171, 10.1016/j.pt.2012.02.004.
10. Basáñez, M.G., McCarthy, J.S., French, M.D., Yang, G.J., Walker, M., Gambhir, M., Prichard, R.K., Churcher, T.S., A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl. Trop. Dis., 6, 2012, e1548, 10.1371/journal.pntd.0001548.
11. Basáñez, M.G., Walker, M., Turner, H.C., Coffeng, L.E., de Vlas, S.J., Stolk, W.A., River blindness: mathematical models for control and elimination. Adv. Parasitol. 94 (2016), 247–341, 10.1016/bs.apar.2016.08.003.
12. Boakye, D.A., Back, C., Fiasorgbor, G.K., Sib, A.P.P., Coulibaly, Y., Sibling species distributions of the Simulium damnosum complex in the West African Onchocerciasis Control Programme area during the decade 1984-93, following intensive larviciding since 1974. Med. Vet. Entomol. 12 (1998), 345–358.
13. Boatin, B., The onchocerciasis control programme in West Africa (OCP). Ann. Trop. Med. Parasitol. 102 (2008), 13–17, 10.1179/136485908x337427.
14. Bottomley, C., Isham, V., Vivas-Martinez, S., Kuesel, A.C., Attah, S.K., Opoku, N.O., Lustigman, S., Walker, M., Basáñez, M.G., Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings. Parasit. Vectors, 9, 2016, 343, 10.1186/s13071-016-1605-3.
15. Churcher, T.S., Ferguson, N.M., Basáñez, M.G., Density dependence and overdispersion in the transmission of helminth parasites. Parasitology 131 (2005), 121–132.
16. Coffeng, L.E., Stolk, W.A., Hoerauf, A., Habbema, D., Bakker, R., Hopkins, A.D., de Vlas, S.J., Elimination of African onchocerciasis: modelling the impact of increasing the frequency of ivermectin mass treatment. PLoS One, 9, 2014, e115886, 10.1371/journal.pone.0115886.
17. Coffeng, L.E., Stolk, W.A., Zoure, H.G., Veerman, J.L., Agblewonu, K.B., Murdoch, M.E., Noma, M., Fobi, G., Richardus, J.H., Bundy, D.A.P., et al. African Programme for Onchocerciasis Control 1995–2015: updated health impact estimates based on new disability weights. PLoS Negl. Trop. Dis., 8, 2014, e2759, 10.1371/journal.pntd.0002759.
18. Convit, J., Schuler, H., Borges, R., Olivero, V., Domínguez-Vázquez, A., Frontado, H., Grillet, M.E., Interruption of Onchocerca volvulus transmission in Northern Venezuela. Parasites Vectors, 6, 2013, 289, 10.1186/1756-3305-6-289.
19. Diawara, L., Traoré, M., Badji, A., Bissan, Y., Doumbia, K., Goita, S.F., Konaté, L., Mounkoro, K., Sarr, M.D., Seck, A.F., et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl. Trop. Dis., 3, 2009, e497, 10.1371/journal.pntd.0000497.
20. Eisenbarth, A., Achukwi, M.D., Renz, A., Ongoing transmission of Onchocerca volvulus after 25 years of annual ivermectin mass treatments in the Vina du Nord river valley, in north Cameroon. PLoS Negl. Trop. Dis., 10, 2016, e0004392.
21. Filipe, J.A.N., Boussinesq, M., Renz, A., Collins, R.C., Vivas-Martinez, S., Grillet, M.E., Little, M.P., Basáñez, M.G., Human infection patterns and heterogeneous exposure in river blindness. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 15265–15270, 10.1073/pnas.0502659102.
22. Frempong, K.K., Walker, M., Cheke, R.A., Tetevi, E.J., Gyan, E.T., Owusu, E.O., Wilson, M.D., Boakye, D.A., Taylor, M.J., Biritwum, N.K., et al. Does increasing treatment frequency address suboptimal responses to ivermectin for the control and elimination of river blindness?. Clin. Infect. Dis. 62 (2016), 1338–1347, 10.1093/cid/ciw144.
23. Gambhir, M., Singh, B.K., Michael, E., The Allee effect and elimination of neglected tropical diseases: a mathematical modelling study. Adv. Parasitol. 87 (2015), 1–31, 10.1016/bs.apar.2014.12.001.
24. Gardon, J., Boussinesq, M., Kamgno, J., Gardon-Wendel, N., Demanga-Ngangue, Duke, B.O., Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomized controlled trial. Lancet 360 (2002), 203–210, 10.1016/S0140-6736(02)09456-4.
25. Golden, A., Faulx, D., Kalnoky, M., Stevens, E., Yokobe, L., Peck, R., Karabou, P., Banla, M., Rao, R., Adade, K., Gantin, R.G., Komlan, K., Soboslay, P.T., de Los Santos, T., Domingo, G.J., Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasit. Vectors, 9, 2016, 388, 10.1186/s13071-016-1623-1.
26. Habbema, J.D.F., De Vlas, S.J., Plaisier, A.P., Van Oortmarssen, G.J., The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. Am. J. Trop. Med. Hyg. 55:Suppl. 5 (1996), 165–169.
27. Higazi, T.B., Zarroug, I.M.A., Mohamed, H.A., ElMubark, W.A., Deran, T.C.M., Aziz, N., Katabarwa, M., Hassan, H.K., Unnasch, T.R., Mackenzie, C.D., et al. Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan. Am. J. Trop. Med. Hyg. 89 (2013), 51–57, 10.4269/ajtmh.13-0112.
28. Hildebrandt, J.C., Eisenbarth, A., Renz, A., Streit, A., Single worm genotyping demonstrates that Onchocerca ochengi females simultaneously produce progeny sired by different males. Parasitol. Res. 111 (2012), 2217–2221, 10.1007/s00436-012-2983-x.
29. Katabarwa, M.N., Eyamba, A., Nwane, P., Enyong, P., Kamgno, J., Kueté, T., Yaya, S., Aboutou, R., Mukenge, L., Kafando, C., et al. Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the West Region of Cameroon. J. Parasitol. Res., 2013, 2013, 420928, 10.1155/2013/420928.
30. Katabarwa, M.N., Lakwo, T., Habomugisha, P., Agunyo, S., Byamukama, E., Oguttu, D., Tukesiga, E., Unoba, D., Dramuke, P., Onapa, A., et al. Transmission of Onchocerca volvulus continues in Nyagak-Bondo focus of northwestern Uganda after 18 years of a single dose of annual treatment with ivermectin. Am. J. Trop. Med. Hyg. 89 (2013), 293–300, 10.4269/ajtmh.13-0037.
31. Katabarwa, M.N., Lakwo, T., Habomugisha, P., Agunyo, S., Byamukama, E., Oguttu, D., Ndyomugyenyi, R., Tukesiga, R., Ochieng, G.O., Abwaimo, F., et al. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted. Am. J. Trop. Med. Hyg. 90 (2014), 1159–1166, 10.4269/ajtmh.13-0501.
32. Kim, Y.E., Remme, J.H.F., Steinmann, P., Stolk, W.A., Roungou, J.P., Tediosi, F., Control, elimination and eradication of river blindness: scenarios, timelines and ivermectin treatment needs in Africa. PLoS Negl. Trop. Dis., 9, 2015, e0003664, 10.1371/journal.pntd.0003664.
33. Koala, L., Nikiema, A., Post, R.J., Paré, A.B., Kafando, C.M., Drabo, F., Traoré, S., Recrudescence of onchocerciasis in the Comé valley in Southwest Burkina Faso. Acta Trop. 166 (2017), 96–105, 10.1016/j.actatropica.2016.11.003.
34. Kuesel, A.C., Research for new drugs for elimination of onchocerciasis in Africa. Int. J. Drugs Drug Resist. 6 (2016), 272–286, 10.1016/j.ijpddr.2016.04.002.
35. Lamberton, P.H.L., Cheke, R.A., Walker, M., Winskill, P., Osei-Atweneboana, M.Y., Tirados, I., Tetteh-Kumah, A., Baokye, D.A., Wilson, M.D., Post, R.J., Basáñez, M.G., Onchocerciasis transmission in Ghana: biting and parous rates of host-seeking sibling species of Simulium damnosum complex. Parasit. Vectors, 7, 2014, 511, 10.1186/s13071-014-0511-9.
36. Lamberton, P.H.L., Cheke, R.A., Winskill, P., Tirado, I., Walker, M., Osei-Atweneboana, M.Y., Biritwum, N.K., Tetteh-Kumah, A., Boakye, D.A., Wilson, M.D., Post, R.J., Basáñez, M.G., Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of simuliid vectors. PLoS Negl. Trop. Dis., 9, 2015, e0003688, 10.1371/journal.pntd.0003688.
37. London Declaration on Neglected Tropical Diseases, Ending the neglect and reaching 2020 goals. 2012 Available at: http://unitingtocombatntds.org/downloads/press/ntd_event_london_declaration_on_ntds.pdf. Accessed 22 August 2016.
38. Lont, Y.L., Coffeng, L.E., de Vlas, S.J., Golden, A., de Los Santos, T., Domingo, G.J., Stolk, W.A., Modelling anti-Ov16 IgG4 antibody prevalence as an indicator for evaluation and decision making in onchocerciasis elimination programmes. PLoS Negl. Trop. Dis., 11, 2017, e0005314, 10.1371/journal.pntd.0005314.
39. Lovato, R., Guevara, A., Guderian, R., Proaño, R., Unnasch, T., Criollo, H., Hassa, H.K., Mackenzie, C.D., Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution. PLoS Negl. Trop. Dis., 8, 2014, e2821, 10.1371/journal.pntd.0002821.
40. May, R.M., Togetherness among schistosomes: its effects on the dynamics of the infection. Math. Biosci. 35 (1977), 301–343.
41. Moreau, J.P., Prost, A., Prod'hon, J., An attempt to normalize the methodology of clinical parasitological surveys of onchocerciasis in West-Africa. Med. Trop. 38 (1978), 43–51.
42. O'Hanlon, S.J., Slater, H.C., Cheke, R.A., Boatin, B.A., Coffeng, L.E., Pion, S.D., Boussinesq, M., Zouré, H.G., Stolk, W.A., Basáñez, M.G., Model-based geostatistical mapping of the prevalence of Onchocerca volvulus in West Africa. PLoS Negl. Trop. Dis., 15, 2016, e0004328, 10.1371/journal.pntd.0004328.
43. Plaisier, A.P., van Oortmarssen, G.J., Habbema, J.D., Remme, J., Alley, E.S., ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput. Methods Progams Biomed. 31 (1990), 43–56.
44. Plaisier, A.P., van Oortmarssen, G.J., Habbema, J.D., Remme, J., The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop. 48 (1991), 271–284.
45. Plaisier, A.P., Alley, E.S., Boatin, B.A., van Oortmarssen, G.J., Remme, J., de Vlas, S.J., Bonneux, L., Habbema, J.D., Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J. Infect. Dis. 172 (1995), 204–210.
46. Plaisier, A.P., Alley, E.S., van Oortmarssen, G.J., Boatin, B.A., Habbema, J.D.F., Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in west Africa. Bull. World Health Organ. 75 (1997), 237–245.
47. Renz, A., Wenk, P., Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area in North Cameroon V. What is a tolerable level of the annual transmission potential?. Annal. Trop. Med. Paraistol. 81 (1987), 263–274.
48. Rodríguez-Pérez, M.A., Fernández-Santos, N.A., Orozco-Algarra, M.E., Rodríguez-Atanacio, J.A., Domínguez-Vázquez, A., Rodríguez-Morales, K.B., Real-Najarro, O., Prado-Velasco, F.G., Cupp, E.W., Richards, F.O. Jr., Hassan, H.K., González-Roldán, J.F., Kuri-Morales, P.A., Unnasch, T.R., Elimination of onchocerciasis from Mexico. PLoS Negl. Trop. Dis., 9, 2015, e0003922, 10.1371/journal.pntd.0003922.
49. Schulz-Key, H., Karam, M., Periodic reproduction of Onchocerca volvulus. Parasitol. Today 2 (1986), 284–286.
50. Stolk, W.A., Walker, M., Coffeng, L.R., Basáñez, M.G., de Vlas, S.J., Required duration of mass ivermectin treatment for onchocerciasis elimimnation in Africa: a comparative modelling analysis. Parasites Vectors, 8, 2015, 552, 10.1186/s13071-015-1159-9.
51. Tekle, A.H., Elhassan, E., Isiyaku, S., Amazigo, U., Bush, S., Noma, M., Cousens, S., Abiose, A., Remme, J.H.F., Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasites Vectors, 5, 2012, 28, 10.1186/1756-3305-5-28.
52. Tekle, A.H., Zouré, H.G., Noma, M., Boussinesq, M., Coffeng, L.E., Stolk, W.A., Remme, J.H.F., Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results. Parasites Vectors, 5, 2016, 66, 10.1186/s40249-016-0160-7.
53. Traore, M.O., Sarr, M.D., Badji, A., Bissan, Y., Diawara, L., Doumbia, K., Goita, S.F., Konate, L., Mounkoro, K., Seck, A.F., et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl. Trop. Dis., 6, 2012, e1825, 10.1371/journal.pntd.0001825.
54. Turner, H.C., Churcher, T.S., Walker, M., Osei-Atweneboana, M.Y., Prichard, R.K., Basáñez, M.G., Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl. Trop. Dis., 7, 2013, e2169, 10.1371/journal.pntd.0002169.
55. Turner, H.C., Walker, M., Churcher, T.S., Osei-Atweneboana, M.Y., Biritwum, N.K., Hopkins, A., Prichard, R.K., Basáñez, M.G., Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin. Infect. Dis 59 (2014), 923–932, 10.1093/cid/ciu467.
56. Turner, H.C., Walker, M., Lustigman, S., Taylor, D.W., Basáñez, M.G., Human onchocerciasis: modelling the potential long-term consequences of a vaccination programme. PLoS Negl. Trop. Dis., 9, 2015, e0003938, 10.1371/journal.pntd.0003938.
57. Turner, H.C., Walker, M., Attah, S.K., Opoku, N.O., Awadzi, K., Kuesel, A.C., Basáñez, M.G., The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasit. Vectors, 8, 2015, 167, 10.1186/s13071-015-0779-4.
58. World Health Organization, Accelerating Work to Overcome the Global Impact of Neglected Tropical 13. Diseases—A Roadmap for Implementation Executive Summary. WHO/HTM/NTD/2012.1. 2012, World Health Organization, Geneva, Switzerland.
59. World Health Organization, Strategic Options and Alternative Treatment Strategies for Accelerating Onchocerciasis Elimination in Africa WHO/MG/15/20. 2015, World Health Organization, Geneva, Switzerland.
60. World Health Organization, Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis WHO/HTM/NTD/PCT/2016.1. 2016, World Health Organization, Geneva, Switzerland.
61. Walker, M., Specht, S., Churcher, T.S., Hoerauf, A., Taylor, M.J., Basáñez, M.G., Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness. Clin. Infect. Dis. 60 (2015), 1199–1207, 10.1093/cid/ciu1152.
62. Wanji, S., Kengne-Ouago, J.A., Esum, M.E., Chounna, P.W.N., Tendongfor, N., Adzemye, B.F., Eyong, J.E.E., Jato, I., Datchoua-Poutche, F.R., Kah, E., et al. Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment. Parasit. Vectors, 8, 2015, 10.1186/s13071-015-0817-2.
63. West, S., Munoz, B., Sommer, A., River blindness eliminated in Colombia. Opthalmic Epidemiol. 20 (2012), 258–259, 10.3109/09286586.2013.836230.
64. Wilson, N.O., Badara Ly, A., Cama, V.A., Cantey, P.T., Cohn, D., Diawara, L., Direny, A., Fall, M., Feeser, K.R., Fox, L.M., Kabore, A., Seck, A.F., Sy, N., Ndiaye, D., Dubray, C., Evaluation of lymphatic filariasis and onchocerciasis in three Senegalese districts treated for onchocerciasis with ivermectin. PLoS Negl. Trop. Dis., 10, 2016, e0005198.
65. Winnen, M., Plaisier, A.P., Alley, E.S., Nagelkerke, N.J., van Oortmarssen, G., Boatin, B.A., Habbema, J.D., Can ivermectin mass treatments eliminate onchocerciasis in Africa?. Bull. World Health Organ. 80 (2002), 384–391.